<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_WGYXW3A">Dose-Dependent Effect of Aerobic Exercise on Inflammatory Biomarkers in a Randomized Controlled Trial of Women at High Risk of Breast Cancer</title>
				<funder ref="#_aJwQkrF #_CjfApkx">
					<orgName type="full">National Center for Advancing Translational Sciences</orgName>
					<orgName type="abbreviated">NCATS</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100006108</idno>
				</funder>
				<funder ref="#_jbK9YVE #_4qZjs5g">
					<orgName type="full">National Cancer Institute at the National Institutes of Health</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">© 2019 American Cancer Society.</p>
				</availability>
				<date type="published" when="2019-09-30">September 30, 2019</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>MSPHS</roleName><forename type="first">Jeremy</forename><forename type="middle">S</forename><surname>Haley</surname></persName>
							<idno type="ORCID">0000-0002-3279-7873</idno>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Public Health Sciences , Penn State Cancer Institute , College of Medicine , Pennsylvania State University , 500 University Dr , Hershey , PA 17033 ;</note>
								<orgName type="department" key="dep1">Department of Public Health Sciences</orgName>
								<orgName type="department" key="dep2">College of Medicine</orgName>
								<orgName type="institution" key="instit1">Penn State Cancer Institute</orgName>
								<orgName type="institution" key="instit2">Pennsylvania State University</orgName>
								<address>
									<addrLine>500 University Dr</addrLine>
									<postCode>17033</postCode>
									<settlement>Hershey</settlement>
									<region>PA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD, MPH</roleName><forename type="first">Elizabeth</forename><forename type="middle">A</forename><surname>Hibler</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> Department of Public Health Sciences , Pennsylvania State University , Hershey , Pennsylvania;</note>
								<orgName type="department">Department of Public Health Sciences</orgName>
								<orgName type="institution">Pennsylvania State University</orgName>
								<address>
									<settlement>Hershey</settlement>
									<region>Pennsylvania;</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Shouhao</forename><surname>Zhou</surname></persName>
							<idno type="ORCID">0000-0002-8124-5047</idno>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Public Health Sciences , Penn State Cancer Institute , College of Medicine , Pennsylvania State University , 500 University Dr , Hershey , PA 17033 ;</note>
								<orgName type="department" key="dep1">Department of Public Health Sciences</orgName>
								<orgName type="department" key="dep2">College of Medicine</orgName>
								<orgName type="institution" key="instit1">Penn State Cancer Institute</orgName>
								<orgName type="institution" key="instit2">Pennsylvania State University</orgName>
								<address>
									<addrLine>500 University Dr</addrLine>
									<postCode>17033</postCode>
									<settlement>Hershey</settlement>
									<region>PA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD, MPH</roleName><forename type="first">Kathryn</forename><forename type="middle">H</forename><surname>Schmitz</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Public Health Sciences , Penn State Cancer Institute , College of Medicine , Pennsylvania State University , 500 University Dr , Hershey , PA 17033 ;</note>
								<orgName type="department" key="dep1">Department of Public Health Sciences</orgName>
								<orgName type="department" key="dep2">College of Medicine</orgName>
								<orgName type="institution" key="instit1">Penn State Cancer Institute</orgName>
								<orgName type="institution" key="instit2">Pennsylvania State University</orgName>
								<address>
									<addrLine>500 University Dr</addrLine>
									<postCode>17033</postCode>
									<settlement>Hershey</settlement>
									<region>PA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD, MTR</roleName><forename type="first">Kathleen</forename><forename type="middle">M</forename><surname>Sturgeon</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Public Health Sciences , Penn State Cancer Institute , College of Medicine , Pennsylvania State University , 500 University Dr , Hershey , PA 17033 ;</note>
								<orgName type="department" key="dep1">Department of Public Health Sciences</orgName>
								<orgName type="department" key="dep2">College of Medicine</orgName>
								<orgName type="institution" key="instit1">Penn State Cancer Institute</orgName>
								<orgName type="institution" key="instit2">Pennsylvania State University</orgName>
								<address>
									<addrLine>500 University Dr</addrLine>
									<postCode>17033</postCode>
									<settlement>Hershey</settlement>
									<region>PA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<note type="raw_affiliation">Division of Cancer Epidemiology and Prevention , Department of Preventive Medicine , Feinberg School of Medicine , Northwestern University , Chicago , Illinois</note>
								<orgName type="department" key="dep1">Division of Cancer Epidemiology and Prevention</orgName>
								<orgName type="department" key="dep2">Department of Preventive Medicine</orgName>
								<orgName type="department" key="dep3">Feinberg School of Medicine</orgName>
								<orgName type="institution">Northwestern University</orgName>
								<address>
									<settlement>Chicago</settlement>
									<region>Illinois</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_gKSCaFQ">Dose-Dependent Effect of Aerobic Exercise on Inflammatory Biomarkers in a Randomized Controlled Trial of Women at High Risk of Breast Cancer</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2019-09-30">September 30, 2019</date>
						</imprint>
					</monogr>
					<idno type="MD5">4E95305A68AED6EE2416F663187A581C</idno>
					<idno type="DOI">10.1002/cncr.32530</idno>
					<note type="submission">Received: November 30, 2018; Revised: August 9, 2019; Accepted: August 28, 2019,</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T10:19+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term xml:id="_yCZZEbZ">aerobic exercise</term>
					<term xml:id="_CzpKssH">biomarkers</term>
					<term xml:id="_w6KXZyy">BRCA</term>
					<term xml:id="_tshreVN">breast cancer</term>
					<term xml:id="_337EGQz">inflammation</term>
					<term xml:id="_HydSDGk">physical activity</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_RrkDx6X"><p xml:id="_ECN7Yf2"><s xml:id="_xHxnbWk">BACKGROUND: Increased levels of inflammation are associated with many diseases, including cancer.</s><s xml:id="_RTtmmay">Physical activity can lower breast cancer risk as well as levels of inflammation.</s><s xml:id="_djYzsh9">The Women In Steady Exercise Research (WISER) Sister trial was a randomized controlled trial that investigated the effects of a dosed, moderate to vigorous, aerobic exercise intervention on levels of inflammation in premenopausal women who were at high risk of developing breast cancer.</s><s xml:id="_qmUmumJ">METHODS: Participants were randomized to control (&lt;75 minutes per week; 41 patients), low-dose exercise (150 minutes per week; 38 patients), or high-dose exercise (300 minutes per week; 37 patients) groups.</s><s xml:id="_kfaRAwu">The 5-menstrual cycles-long, home-based treadmill exercise intervention gradually increased in minutes per week and intensity up to a maximum of 80% of the age-predicted maximum heart rate.</s><s xml:id="_7d6uTkA">Blood was collected at baseline and at follow-up and assayed for chemokine (C-C motif) ligand 2 (CCL2), interleukin 10 (IL-10), interleukin 12 (IL-12), and tumor necrosis factor α (TNF-α).</s><s xml:id="_c7MSsHF">RESULTS: A linear dose-response relationship was observed for the proinflammatory biomarkers CCL2 (%Δ of -5.44% in the control group, -0.03% in the low-dose exercise group, and 1.54% in the high-dose exercise group), IL-12 (%Δ of -21.5% in the control group, 38.2% in the low-dose exercise group, and 25.8% in the high-dose exercise group,) and TNF-α (%Δ of -4.69% in the control group, 9.51% in the low-dose exercise group, and 15.7% in the high-dose exercise group) but not for the anti-inflammatory biomarker IL-10 (%Δ of 5.05% in the control group, 6.05% in the low-dose exercise group, and 10.6% in the high-dose exercise group).</s><s xml:id="_QVEjzEZ">For IL-12 and TNF-α, the percentage change was significantly higher in the low-dose (IL-12: P &lt; .001;</s><s xml:id="_CyqDseg">and TNF-α: P = .01)</s><s xml:id="_b7weJff">and high-dose (IL-12: P &lt; .001;</s><s xml:id="_DnCe3tm">and TNF-α: P &lt; .001)</s><s xml:id="_cvevVb4">exercise groups compared with the control group.</s><s xml:id="_aZ2QVxC">CONCLUSIONS: Moderate to vigorous aerobic exercise appeared to increase levels of proinflammatory biomarkers in a dose-dependent manner in a population of healthy women at high risk of developing breast cancer.</s><s xml:id="_gYKUExJ">The results of the current study suggest that for healthy premenopausal women, the mechanism of reduced breast cancer risk observed in physically active individuals may not be a result of reduced levels of inflammation.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="584.787" lry="782.929"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="584.787" lry="782.929"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="584.787" lry="782.929"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="584.787" lry="782.929"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="584.787" lry="782.929"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="584.787" lry="782.929"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="584.787" lry="782.929"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="584.787" lry="782.929"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_sntGeXq">INTRODUCTION</head><p xml:id="_q2DtyVU"><s xml:id="_jEXyzZv">On average, women have a 12% lifetime risk of developing breast cancer, <ref type="bibr" target="#b0">1</ref> and there are several factors involved in its carcinogenesis such as sex hormones, 2 growth factors, <ref type="bibr" target="#b2">3</ref> and adipokines. <ref type="bibr" target="#b3">4</ref></s><s xml:id="_GrdSaU2">Women may be at an elevated risk of developing breast cancer if they possess additional risk factors, including breast cancer-associated mutations <ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b5">6</ref> or increased levels of inflammatory biomarkers. <ref type="bibr" target="#b6">7</ref></s><s xml:id="_cDJTxdX">Physical activity has been shown to reduce breast cancer risk. <ref type="bibr" target="#b7">8</ref></s><s xml:id="_pwuCTTT">Premenopausal women who exercise (≥39 metabolic equivalent for task [MET] hours per week) can reduce their risk of breast cancer by 23% compared with physically inactive women. <ref type="bibr" target="#b8">9</ref></s><s xml:id="_HhzpbCH">One mechanism through which physical activity is hypothesized to decrease cancer risk is by decreasing levels of inflammation.</s></p><p xml:id="_nsJv64x"><s xml:id="_ycUbdCJ">Inflammation is associated with an increased risk of disease. <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b10">11</ref></s><s xml:id="_nhanMUn">Specifically, increased levels of proinflammatory biomarkers such as tumor necrosis factor α (TNF-α), interleukin 12 (IL-12; IL-12p70 active heterodimer), and chemokine (C-C motif ) ligand 2 (CCL2) have been implicated in the development and progression of cancer. <ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref></s><s xml:id="_c9NHCay">3]<ref type="bibr" target="#b13">[14]</ref> Antiinflammatory biomarkers such as IL-10 are responsible for controlling the inflammatory response by inhibiting the production of proinflammatory biomarkers by inflammatory macrophages. <ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b15">16</ref></s><s xml:id="_4XHMVbg">Failure to resolve an inflammatory response can result in a chronic state of inflammation that is characterized by persistent, low levels of proinflammatory biomarkers and inflammatory cells, even in the absence of injury or infection, that can cause harm to healthy tissue.</s></p><p xml:id="_S8Uymm2"><s xml:id="_PPVWy8A">Mitigating chronic inflammation may be particularly important for women at high risk of breast cancer.</s><s xml:id="_VdVcFJR">Cells in an inflammatory environment are known to produce free radicals such as reactive oxygen and nitrogen species. <ref type="bibr" target="#b16">17</ref></s><s xml:id="_n7gjyBJ">Through Cancer January 15, 2020 oxidative stress, these free radicals are capable of damaging DNA and preventing DNA repair.</s><s xml:id="_5vqxtWW">In addition, mutations in genes that are associated with an increased risk of breast cancer (BRCA1/2 and PALB2) also are key components of the DNA repair process. <ref type="bibr" target="#b17">18</ref></s><s xml:id="_RBkQMhp">Furthermore, mutations in genes associated with the DNA damage response also can increase a woman's risk of breast cancer. <ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b2">3</ref></s><s xml:id="_srxXVPT">Thus, reducing chronic inflammation via the implementation of healthy lifestyle changes in women with deficiencies in DNA repair processes may be particularly important.</s></p><p xml:id="_ryGeWkE"><s xml:id="_AsCTDbR">Several studies in women have observed physical activity-induced decreases in proinflammatory biomarkers and increases in anti-inflammatory biomarker levels. <ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref></s><s xml:id="_zAfvMQh">0]<ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref> Despite data from observational studies regarding physical activity and interventional studies using structured exercise interventions <ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b21">22</ref> demonstrating that both can improve levels of inflammatory biomarkers, to the best of our knowledge no randomized controlled intervention trial to date has assessed whether structured aerobic exercise is able to change levels of inflammation in a dose-dependent manner in a population of women at high risk of developing breast cancer.</s><s xml:id="_PAt2jc2">Studies that have been performed in high-risk women, specifically BRCA1/2 carriers, primarily have focused on observational data exploring the relationship between levels of physical activity and breast cancer risk.</s><s xml:id="_Spph7X7">These data have shown that physical activity early in life can reduce breast cancer risk. <ref type="bibr" target="#b22">23</ref></s><s xml:id="_fZSUSdz">It is important to note that these observational studies have assessed general physical activity (defined as any bodily movement produced by skeletal muscles that requires energy expenditure).</s><s xml:id="_RE3AXdF">Exercise is a subtype of physical activity.</s><s xml:id="_p4HJx2e">Exercise is planned, structured, and intentional movement with the goal of improving or maintaining physical fitness.</s><s xml:id="_EYVA7rq">Exercise physiology has indicated that the body reacts and adapts to different physical stressors (frequency, intensity, and duration) in unique ways.</s><s xml:id="_SN2QUW5">Thus, the objective of the current prospective, randomized controlled trial was to assess the effect of a dosed aerobic exercise intervention on levels of inflammation in premenopausal women at high risk of breast cancer.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_PJsM8sm">MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_EWjGFm5">Eligibility, Recruitment, and Randomization</head><p xml:id="_CvTPhrb"><s xml:id="_bPRkduJ">The Women In Steady Exercise Research (WISER) Sister study was a randomized controlled trial of premenopausal women at high risk of developing breast cancer that enrolled participants from 2008 through 2012.</s><s xml:id="_GDUk4V6">Detailed information regarding study recruitment, randomization, the intervention, and main results (improvements in body composition, hormone levels, breast density, adiponectin, and leptin) have been reported previously. <ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref></s><s xml:id="_nEyvvp8">]<ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref> Briefly, eligible participants were considered to be at high risk if they possessed any of the following: 1) confirmed BRCA1/2 mutation; 2) a lifetime risk of developing breast cancer of ≥18% according to the Gail or Claus prediction models; or 3) documented deleterious mutation in a relative that conferred a &gt;25% risk to the participant.</s><s xml:id="_m6n5Ae9">Eligibility criteria also included age &gt;18 years; normal menstrual cycles; not currently smoking; body mass index (BMI) of 18 to 50 kg/m 2 and weight stable; no history of fibroids, endometriosis, or polycystic ovary syndrome; no recent use of hormonal contraception; no contraindications for exercise training; controlled hypertension; and sedentary lifestyle (&lt;75 minutes of aerobic exercise per week).</s><s xml:id="_aBpYp6y">The University of Pennsylvania Human Subjects Review Committee approved the current study, and written informed consent was obtained from all subjects before study activities were initiated.</s></p><p xml:id="_yR2M2uT"><s xml:id="_N7jHwdB">Women were randomized to control or intervention groups after stratification by: 1) baseline BMI &gt;30 kg/m 2 and &lt;30 kg/m 2 ; and 2) time since first menstrual cycle (&gt;10 years vs ≤10 years).</s><s xml:id="_rNtc6kY">In the current study, 132 participants had available samples at baseline and 116 of those women also had follow-up samples available.</s><s xml:id="_uStjJDY">Sixteen women were lost to follow-up.</s><s xml:id="_uBC7AGf">Baseline analyses of TNF-α and IL-12 included all 132 women (43 women in the control group, 44 women in the low-dose exercise group, and 45 women in the high-dose exercise group).</s><s xml:id="_qnDYFPD">Baseline analysis of CCL2 and IL-10 included 131 participants.</s><s xml:id="_qGdwKuj">Two data points at baseline were excluded due to technical error: CCL2 (43 women in the control group, 43 women in the low-dose exercise group, and 45 women in the high-dose exercise group) and IL-10 (42 women in the control group, 44 women in the low-dose exercise group, and 45 women in the high-dose exercise group).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_G2Mp9nx">Exercise Intervention</head><p xml:id="_sAzCD9n"><s xml:id="_XGdkPnG">A 5-menstrual cycle-long exercise intervention was selected to be long enough to induce changes in urinary hormones (primary outcome of the WISER Sister Trial), while balancing the feasibility of recruitment, complexity of delivering a distance-based intervention, and completing the study within the funding period. <ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b27">28</ref></s><s xml:id="_V5nbfUG">articipants in the low-dose and high-dose aerobic exercise groups were asked to complete 150 minutes of exercise per week and 300 minutes of exercise per week, respectively.</s><s xml:id="_a2QZNZb">Participants within an intervention group had treadmills shipped to their home (Smooth Fitness 5.65 Treadmill; Smooth Fitness, King of Prussia, Pennsylvania) and were Cancer January 15, 2020 asked to complete home-based aerobic workouts for 5 menstrual cycles.</s><s xml:id="_SaSdkxQ">Exercise intensity progressed in the first 4 weeks of the intervention for both groups until 70% to 80% of the age-predicted maximum heart rate (220-age) was attained. <ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b26">27</ref></s><s xml:id="_sTrKwtg">After the first 4 weeks, the high-dose exercise group increased their exercise duration by 20 to 25 minutes every 2 weeks until reaching 300 minutes per week.</s><s xml:id="_Vn2ygHG">Exercise intensity did not differ between the intervention groups.</s><s xml:id="_Q5NfrNQ">Participants in the control group were asked to maintain their regular physical activity levels (&lt;75 minutes/week).</s><s xml:id="_JSDTFcs">Adherence to the exercise protocol was monitored by review of the participants' exercise logs and heart rate monitor data as previously reported. <ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b26">27</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_z8bPCGu">Data Collection</head><p xml:id="_wFmU7nD"><s xml:id="_SPgg6G9">Data collection was performed at baseline and at followup clinic visits.</s><s xml:id="_u8E3vWQ">Participants completed 3-day dietary logs.</s><s xml:id="_37JuVSF">Body composition variables were measured using dualenergy x-ray absorptiometry (Hologic, Marlborough, Massachusetts) and all scans were analyzed using APEX 3.3.</s><s xml:id="_FAcWgYf">Fitness capacity was assessed using time completed in a Bruce protocol treadmill exercise test.</s><s xml:id="_j6M7mRF">Energy expenditure was measured using a modified version of the Modifiable Activity Questionnaire. <ref type="bibr" target="#b28">29</ref></s><s xml:id="_SdYprmr">Biomarkers were assessed in fasted plasma samples stored at -80 °C.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_KnmQrTP">Measuring Concentrations of Inflammatory Biomarkers</head><p xml:id="_jmvPE7Q"><s xml:id="_YTgcTqA">Levels of TNF-α, IL-12, CCL2, and IL-10 were assessed using ELLA Simple Plex technology (Protein Simple) following the manufacturer's protocol. <ref type="bibr" target="#b29">30</ref></s><s xml:id="_HVtUxqc">lasma samples were thawed at room temperature and then diluted 1:2 in Sample Diluent.</s><s xml:id="_U8BFDjP">A total of 50 uL of diluted plasma was added to each sample well and then directed down 4 separate channels that contained a capture antibody for one of the biomarkers.</s><s xml:id="_RVVZYzW">Each channel assessed antibody capture in triplicate and then was quantified using a preloaded calibration curve.</s><s xml:id="_2ytzXMS">Intra-assay coefficient of variation (CV%) for each analyte was 3.2% for TNF-α, 7.2% for IL-12, 3.3% for CCL2, and 2.6% for IL-10.</s><s xml:id="_YfNFMtV">The limit of detection for each analyte was 0.278 pg/mL for TNF-α, 0.39 pg/mL for IL-12, 0.35 pg/mL for CCL2, and 0.14 pg/mL for IL-10.</s><s xml:id="_fv2wXnR">Concentrations were measured and analyzed using Simple Plex Runner software (version v.3.3.0.98).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_9nWpAE6">Statistical Analysis</head><p xml:id="_bJqpNKR"><s xml:id="_YudkQvy">Normality was tested first and either Wilcoxon signed rank tests or Student t tests for paired data were used accordingly to assess changes within the group from baseline to follow-up.</s><s xml:id="_9vkFJGA">Independent 2-sample Student t tests assessed baseline differences between women who completed the study and women who withdrew from the study.</s><s xml:id="_hS6psxz">Correlations between variables were performed using the Pearson correlation test.</s><s xml:id="_z5vvbXN">A one-way analysis of variance was used to test for differences in the percentage change in biomarkers between the intervention groups after logarithmic transformation on the ratio.</s><s xml:id="_PdSWa9P">Baseline-adjusted linear regression was used to evaluate the absolute change in biomarker concentration after the intervention period.</s><s xml:id="_GzxWuYz">An extension of the Wilcoxon rank sum test was used to test for linear trends across groups.</s><s xml:id="_bknpfaf">Statistical analyses were conducted using Stata statistical software (version 12; StataCorp LLC, College Station, Texas).</s><s xml:id="_tUtAnFF">The false discovery rate due to multiple testing was controlled for using the method of Benjamini and Hochberg. <ref type="bibr" target="#b30">31</ref></s><s xml:id="_eaRsJV8">Statistical significance was set at an α level of .05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_q8AhAxN">RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_f5ecssN">Demographics</head><p xml:id="_MfyCk6U"><s xml:id="_8wt4yFs">Demographic information is shown in Table <ref type="table" target="#tab_0">1</ref>.</s><s xml:id="_57BAMYX">The study population (132 women) had a mean age of 34.4 years and predominantly was white (85.6%), non-Hispanic Cancer January 15, 2020 (92.4%), and overweight (BMI of 26.8 kg/m 2 ).</s><s xml:id="_2M85VNS">Compared with the control and high-dose exercise groups, women in the low-dose exercise group were significantly more likely to be married/partnered and to have children.</s><s xml:id="_5WwbSD2">In addition, it previously was reported that BRCA1/2 mutation status, caloric intake, body fat percentage, and intervention adherence (percentage of the total prescribed minutes completed: low-dose exercise group, 85% and high-dose exercise group, 81%; percentage with ≥80% adherence: low-dose exercise group, 76% and high-dose exercise group, 75%) <ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref> were not found to be significantly different between groups.</s></p><p xml:id="_WZwKQvJ"><s xml:id="_DMW5qH3">A sensitivity analysis was conducted to compare baseline measurements between the 16 women who withdrew from the study prior to follow-up and the 116 women who completed the study (data not shown).</s><s xml:id="_Rc8DbdH">Reasons for withdrawal from the study have been reported previously, <ref type="bibr" target="#b24">25</ref> with time pressures and family issues given as the primary reasons.</s><s xml:id="_r2dcgEb">The majority of women who withdrew from the study were from the intervention groups (87.5%).</s><s xml:id="_fxKfJEB">Women who withdrew from the study were significantly different from study participants in that they were younger (aged 30.6 years vs aged 34.8 years; P = .02),</s><s xml:id="_pYd8qQ8">had a higher BMI (31.5 kg/m 2 vs 26.2 kg/m 2 ; P &lt; .01),</s><s xml:id="_hPGsrqN">and were less fit (treadmill time of 6.96 minutes vs 8.27 minutes; P &lt; .01).</s><s xml:id="_5DgEAmR">They also were found to be significantly less likely to be married/partnered (P &lt; .01), to be white (P &lt; .01),</s><s xml:id="_mj4n2Af">and to have completed higher levels of education (P &lt; .01).</s><s xml:id="_TsGzuvY">The concentrations of biomarkers were not significantly different between study participants and women who withdrew from the study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_93HqU7Q">Correlation of Baseline Variables</head><p xml:id="_h54hHDF"><s xml:id="_AYsTaEg">A correlation analysis was performed at baseline to assess associations between inflammatory biomarkers and measures of body composition, fitness capacity, and energy balance (Table <ref type="table" target="#tab_1">2</ref>).</s><s xml:id="_aHTUqKk">We observed a significantly positive association between levels of TNF-α and all other biomarkers (CCL2: correlation coefficient [r] = 0.275; IL-10: r = 0.268; and IL-12: r = 0.261).</s><s xml:id="_WbdxmAQ">Higher levels of TNF-α also were found to be significantly associated with higher BMI (r = 0.231).</s><s xml:id="_vmvdRVZ">IL-12 was significantly associated with a higher caloric intake (r = 0.237) and higher fitness capacity (r = 0.206).</s><s xml:id="_x28HM4v">Energy expenditure and body fat percentage were not found to be significantly correlated with any of the biomarkers.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_bnfkchC">Change in Inflammatory Biomarkers</head><p xml:id="_sFhQaGD"><s xml:id="_JcTGk9V">Absolute change in biomarker concentration from baseline to follow-up was assessed within and between groups (Table <ref type="table" target="#tab_2">3</ref>).</s><s xml:id="_62TrgFP">Control group participants experienced significant decreases in the proinflammatory biomarkers CCL2 (-11.9 pg/mL), IL-12 (-0.4 pg/mL), and TNF-α (-0.4 pg/mL).</s><s xml:id="_hmEdSN7">The high-dose exercise group experienced a significant increase in TNF-α levels (0.7 pg/mL) after the intervention period, whereas the other proinflammatory biomarkers did not appear to change.</s><s xml:id="_GgZXK7Q">Levels of proinflammatory biomarkers did not significantly change among women in the low-dose exercise group.</s><s xml:id="_AwrPFca">Finally, levels of the anti-inflammatory biomarker IL-10 did not significantly change within any group.</s><s xml:id="_zu3Yeup">Between groups, the changes in IL-12 and TNF-α concentrations in the low-dose exercise and high-dose exercise groups were significantly different from those of the control group, whereas the changes in concentrations of CCL2 and IL-10 were not significantly different between groups.</s></p><p xml:id="_a9azAs6"><s xml:id="_xQnmnyQ">The percentage change in biomarker levels was calculated and compared between groups.</s><s xml:id="_k62CMZN">We further tested whether the observed changes in biomarker Cancer January 15, 2020 levels changed linearly as the dose of exercise increased (Fig. <ref type="figure" target="#fig_0">1</ref>).</s><s xml:id="_wFCSyfD">The percentage change of both IL-12 (36.6% ± 65.6% in the low-dose exercise group and 25.8% ± 50.2% in the high-dose exercise group) and TNF-α (12.4% ± 31.7% in the low-dose exercise group and 15.7% ± 15.9% in the high-dose exercise group) was significantly different from the change in the control group (-22.0%</s><s xml:id="_Bd3RaW9">± 30.3% for IL-12 and -4.8% ± 20.0% for TNF-α).</s><s xml:id="_576F8wY">These changes also were found to be significantly dependent on exercise dose (P for trend, &lt;.01) (Figs.</s><s xml:id="_PChpuVW"><ref type="figure" target="#fig_0">1C</ref> and <ref type="figure" target="#fig_0">1D</ref>).</s><s xml:id="_CVZCYBA">Although the percentage change in CCL2 was not significantly different between groups (-5.3% ± 20.7% in the control group, -0.1% ± 20.7% in the low-dose exercise group, and 1.54% ± 19.7% in the high-dose exercise group), there was a significant dose response effect of the intervention (P for trend, &lt;.05) (Fig. <ref type="figure" target="#fig_0">1A</ref>).</s><s xml:id="_n3WDPbs">The percentage change in IL-10 (5.05% ± 31.7% in the control group, 6.14% ± 20.9% in the low-dose exercise group, and10.5% ± 37.8% in the high-dose exercise group) was not significantly different between groups, nor was there a significant dose-dependent effect of exercise noted (Fig. <ref type="figure" target="#fig_0">1B</ref>).</s><s xml:id="_GZGswUC">The percentage changes in biomarkers between the low-dose exercise and high-dose exercise intervention groups were not significantly different.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Pu4QnX2">DISCUSSION</head><p xml:id="_5FYQ8fj"><s xml:id="_RyKrQVk">To the best of our knowledge, the current study is the first randomized controlled trial to examine the effect of a dosed 5-menstrual cycle-long, moderate to vigorous aerobic exercise intervention on circulating levels of CCL2, IL-10, IL-12, and TNF-α in a national cohort of premenopausal women at risk of developing breast cancer.</s><s xml:id="_ZkW6hVy">We observed significant exercise dose-dependent increases in the concentrations of the proinflammatory biomarkers CCL2, IL-12, and TNF-α.</s><s xml:id="_t4YjgFE">Control group participants experienced significant decreases in their levels of proinflammatory cytokines whereas the intervention groups experienced increases in the levels of proinflammatory biomarkers.</s><s xml:id="_QGgbNs4">The increase in inflammatory biomarker levels was most striking with regard to TNF-α levels among participants in the high-dose exercise group (15.7% ± 15.9%).</s><s xml:id="_qD4t89y">In addition, the increases in TNF-α and IL-12 levels within both the lowdose and high-dose exercise groups were significantly different from the decreases observed in the control group.</s></p><p xml:id="_Zvj49PV"><s xml:id="_aChVBpr">Despite the conventional wisdom that structured exercise decreases levels of proinflammatory biomarkers, there have been studies that also report increases.</s><s xml:id="_WrKvcSN">Hayase et al observed that premenopausal women (9 patients), but not postmenopausal women (9 patients), had significantly increased levels of TNF-α after 10 weeks of aqua aerobics (120 minutes per week) and resistance training (60 minutes per week). <ref type="bibr" target="#b31">32</ref></s><s xml:id="_YQp3UGh">They also demonstrated that this increase in TNF-α was significantly correlated with a decrease in visceral fat tissue (r = -0.816;</s><s xml:id="_za43ZdT">P &lt; .05). Brown et al reported that participants in the WISER Sister study from the low-dose and high-dose exercise groups had significantly decreased levels of visceral adipose tissue compared with control group participants, <ref type="bibr" target="#b26">27</ref> which may have influenced the increase in TNF-α levels noted in the current study.</s></p><p xml:id="_976h5Zp"><s xml:id="_R5ECjgk">There also is evidence in the literature that inflammatory biomarkers are not changed after an exercise intervention.</s><s xml:id="_y6NSRty">In one example, 100 women (aged 54.4 ± 7.1 years, 34% of whom were premenopausal) who participated in a 12-month aerobic exercise intervention (60 minutes per day for 6 days per week, 60%-85% of the maximum heart rate) experienced unchanged levels of inflammation, as measured via C-reactive protein (CRP), despite improvements in body composition and fitness capacity. <ref type="bibr" target="#b32">33</ref></s><s xml:id="_qN2tSVu">However, after a stratified analysis of women with BMIs &gt;30 kg/m 2 and &lt;30 kg/m 2 , a trend Cancer January 15, 2020 was observed that women with a higher baseline BMI reduced their CRP levels more than women with a lower BMI.</s><s xml:id="_N5GTetz">This observation may help to explain why women in the current study with an average BMI of 26.8 kg/m 2 did not experience a decrease in levels of proinflammatory biomarkers.</s></p><p xml:id="_8Pmnktt"><s xml:id="_7HqSGhx">Although the current study did not assess CRP, the inflammatory biomarkers were chosen to represent various facets of the inflammatory response.</s><s xml:id="_Pd9wk6r">CCL2 aids in the recruitment and activation of monocytes and macrophages in mammary tissue, <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b33">34</ref> and it also has been associated with increased stromal density of mammary glands, which is a risk factor for breast cancer. <ref type="bibr" target="#b34">35</ref></s><s xml:id="_gR92Ayj">TNF-α signals through the TNF receptor 1, which is expressed by all human tissue, and intracellular responses to TNF-α include regulation of apoptosis and the production of cytokines. <ref type="bibr" target="#b35">36</ref></s><s xml:id="_BKDxfDD">IL-12 is highly involved in the functional activity of natural killer cells and T lymphocytes, and for this reason this proinflammatory cytokine can have beneficial or detrimental effects. <ref type="bibr" target="#b36">37,</ref><ref type="bibr" target="#b37">38</ref></s><s xml:id="_bUu4qzY">IL-10 plays a major role in resolving the inflammatory response.</s></p><p xml:id="_kbbnXBy"><s xml:id="_jPMFSJV">The population in the current study included adult (aged 34.4 ± 7.0 years), slightly overweight (BMI of 26.8 ± 6.3 kg/m 2 ), but otherwise healthy, premenopausal women.</s><s xml:id="_nT75eK3">It was not anticipated that this cohort would have elevated levels of inflammation at baseline, Cancer January 15, 2020 but it was hypothesized that the exercise intervention herein could decrease biomarkers of inflammation further.</s><s xml:id="_q8JruSQ">All participants initiated the study with similar levels of each biomarker, suggesting that changes in the measured biomarkers of inflammation were an effect of the intervention, and that consistent (&gt;80% of the total prescribed minutes of exercise were completed) <ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref> and chronic (approximately 6 months on average) exercise training increased levels of inflammatory biomarkers.</s><s xml:id="_hGmpPTK">These results need to be taken in context with prior reports from the WISER Sister study.</s><s xml:id="_zby7KV6">Our previous work has demonstrated an exercise dose-dependent decrease in leptin levels, estrogen-sensitive breast tissue, and body fat. <ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref></s><s xml:id="_zww4uR7">6]<ref type="bibr" target="#b26">[27]</ref> Thus, given the full scope of physiological changes observed from this interventional study, we can speculate that in healthy women who are at risk of developing breast cancer, exercise-induced changes in adipokines, body composition, and fibroglandular breast tissue may be more meaningful mechanistically for protection against breast cancer than exerciseinduced changes in systemic inflammation.</s></p><p xml:id="_EyWdxgw"><s xml:id="_m6qhKxE">A major strength of the current study was the high level of adherence to the exercise intervention in both the low-dose and high-dose exercise groups.</s><s xml:id="_xBNHngU">The current study allowed for a more direct interpretation of the effect of exercise on inflammation by focusing on the volume of exercise rather than varying exercise intensity or including a caloric restriction component.</s><s xml:id="_vMcnWvy">The inclusion of a control sedentary group for comparison of inflammation levels with the intervention groups was an additional strength.</s><s xml:id="_pX2DGHE">Finally, this study focused solely on a national sample of women at high genetic risk of breast cancer who otherwise were healthy without other known diseases. <ref type="bibr" target="#b23">24</ref></s><s xml:id="_Au8qqmM">To the best of our knowledge, this population of women is underrepresented in the literature regarding inflammation and structured exercise.</s><s xml:id="_4qvrm58">The current study has several limitations, one of which is the selection of 4 cytokines.</s><s xml:id="_a9dS8s6">The inclusion of additional proinflammatory and anti-inflammatory biomarkers and their receptors would provide a more complete inflammatory profile that may explain the changes we observed in the panel in the current study.</s><s xml:id="_hca7tdx">Future studies also will need to assess a more stable marker of inflammation, such as CRP.</s><s xml:id="_RDEkTbq">Last, the population in the current study predominantly was educated white women, which limits the application of its findings to other women more broadly.</s></p><p xml:id="_HnVcJXK"><s xml:id="_khQdU6A">Overall, the results of the current study demonstrated clear increases in levels of proinflammatory biomarkers after a 5-menstrual cycle-long, moderate to vigorous aerobic exercise intervention.</s><s xml:id="_X4qVDqD">Despite the increase in levels of inflammation in these women at high risk of developing breast cancer, the WISER Sister study has been shown to improve hormone levels, breast density, body composition, fitness capacity, and energy expenditure. <ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref></s><s xml:id="_VVrvCXV">]<ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref> Overall, the information gained from the WISER Sister study indicates that for healthy premenopausal women, the mechanism of reduced breast cancer risk observed in physically active individuals may not occur as a result of reduced levels of inflammation.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p xml:id="_CDD2ewU"><s xml:id="_kBpvFXQ">Figure 1.</s><s xml:id="_GpfkVGv">Percentage change in biomarker concentration after the intervention.</s><s xml:id="_SratnPc">Percentage change in biomarker concentration was compared between groups.</s><s xml:id="_Jea49NQ">Linear trend analysis assessed whether the percentage change in concentration was exercise dosedependent.</s><s xml:id="_bBM7SyJ">CCL2 indicates chemokine (C-C motif) ligand 2; IL-10, interleukin 10; IL-12p70, interleukin 12 (p70 active heterodimer); NS, not significant; TNF-α, tumor necrosis factor α. *P &lt; .05;</s><s xml:id="_b6WG4VT">**P &lt; .01;</s><s xml:id="_Xk25dt5">***P &lt; .001.</s></p></div></figDesc><graphic coords="6,51.46,77.41,481.86,395.22" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>TABLE 1 .</head><label>1</label><figDesc><div><p xml:id="_jhBHPtj"><s xml:id="_TdNMkTa">Demographics of Randomized Women in the Current Study</s></p></div></figDesc><table><row><cell></cell><cell>Total Sample</cell><cell>Control</cell><cell>Low-Dose Exercise</cell><cell>High-Dose Exercise</cell><cell></cell></row><row><cell>Variables</cell><cell>N = 132</cell><cell>N = 43</cell><cell>N = 44</cell><cell>N = 45</cell><cell>P</cell></row><row><cell>Mean age ± SD, y Mean BMI ± SD, kg/m 2</cell><cell>34.4 ± 7.0 26.8 ± 6.3</cell><cell>34.5 ± 7.6 27.0 ± 6.2</cell><cell>35.2 ± 6.5 26.7 ± 6.1</cell><cell>33.4 ± 6.9 26.7 ± 6.7</cell><cell>.47 .97</cell></row><row><cell>Mean age at menarche ± SD, y</cell><cell>12.5 ± 1.4</cell><cell>12.9 ± 1.4</cell><cell>12.3 ± 1.5</cell><cell>12.3 ± 1.4</cell><cell>.09</cell></row><row><cell>Mean body fat ± SD, %</cell><cell>39.0 ± 6.68</cell><cell>39.2 ± 6.73</cell><cell>39.6 ± 6.07</cell><cell>38.2 ± 7.25</cell><cell>.59</cell></row><row><cell>Have children, no. (%)</cell><cell>80 (60.6)</cell><cell>22 (51.2)</cell><cell>34 (77.3)</cell><cell>24 (53.3)</cell><cell>.02</cell></row><row><cell>Married/partnered, no. (%)</cell><cell>81 (61.4)</cell><cell>21 (48.8)</cell><cell>34 (77.3)</cell><cell>26 (57.8)</cell><cell>.02</cell></row><row><cell>Race, no. (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>White</cell><cell>113 (85.6)</cell><cell>37 (86.0)</cell><cell>39 (88.6)</cell><cell>37 (82.2)</cell><cell>.69</cell></row><row><cell>Ethnicity, no. (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Hispanic</cell><cell>10 (7.6)</cell><cell>3 (7.0)</cell><cell>3 (6.8)</cell><cell>4 (8.9)</cell><cell>.92</cell></row><row><cell cols="5">Abbreviations: BMI, body mass index; High-Dose Exercise, 300 minutes per week; Low-Dose Exercise, 150 minutes per week.</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>TABLE 2 .</head><label>2</label><figDesc><div><p xml:id="_gMktaWB"><s xml:id="_cZvVfZ4">Baseline Correlations Between Markers of Inflammation, Body Composition, Fitness Capacity, and Energy Balance</s></p></div></figDesc><table><row><cell></cell><cell>CCL2, pg/mL</cell><cell>IL-10, pg/mL</cell><cell>IL-12, pg/mL</cell><cell>TNF-α, pg/mL</cell></row><row><cell>CCL2, pg/mL</cell><cell>1</cell><cell></cell><cell></cell><cell></cell></row><row><cell>IL-10, pg/mL</cell><cell>0.017</cell><cell>1</cell><cell></cell><cell></cell></row><row><cell>IL-12p70, pg/mL TNF-α, pg/mL</cell><cell>-0.053 0.275 a</cell><cell>0.001 0.268 a</cell><cell>1 0.261 a</cell><cell>1</cell></row><row><cell>BMI, kg/m 2</cell><cell>0.151</cell><cell>-0.013</cell><cell>-0.125</cell><cell>0.231 a</cell></row><row><cell>Body fat, % Exercise test, min</cell><cell>0.110 -0.125</cell><cell>-0.076 0.056</cell><cell>-0.167 0.206 b</cell><cell>0.136 -0.165</cell></row><row><cell>Energy expenditure, MET h/wk Caloric intake, kcal/d</cell><cell>0.077 -0.032</cell><cell>-0.063 -0.129</cell><cell>0.127 0.237 b</cell><cell>-0.139 0.049</cell></row><row><cell cols="5">Abbreviations: BMI, body mass index; CCL2, chemokine (C-C motif) ligand 2; IL-10, interleukin 10; IL-12, interleukin 12; IL-12p70, interleukin 12 (p70 active heter-</cell></row><row><cell cols="2">odimer); MET, metabolic equivalent for task; TNF-α, tumor necrosis factor α.</cell><cell></cell><cell></cell><cell></cell></row></table><note xml:id="_bmdpnBd"><p><s xml:id="_7BdF8cv">a P &lt; .01</s><s xml:id="_bQvEnJA">(statistically significant correlation).</s><s xml:id="_tVYymFe">b P &lt; .05</s><s xml:id="_ZSSGV3X">(statistically significant correlation).</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>TABLE 3 .</head><label>3</label><figDesc><div><p xml:id="_ptqxZav"><s xml:id="_EjnXReC">Absolute Changes in Biomarker Concentrations After the Intervention</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell>Control</cell><cell></cell><cell cols="3">Low-Dose Exercise</cell><cell cols="3">High-Dose Exercise</cell></row><row><cell></cell><cell>Baseline</cell><cell>Follow-Up</cell><cell>Absolute</cell><cell>Baseline</cell><cell>Follow-Up</cell><cell>Absolute</cell><cell>Baseline</cell><cell>Follow-Up</cell><cell>Absolute</cell></row><row><cell>Biomarkers</cell><cell>N = 43</cell><cell>N = 41</cell><cell>Change</cell><cell>N = 44</cell><cell>N = 38</cell><cell>Change</cell><cell>N = 45</cell><cell>N = 37</cell><cell>change</cell></row><row><cell>CCL2, pg/mL</cell><cell cols="5">163.2 ± 44.6 151.2 ± 42.1 a -11.9 ± 37.0 161.1 ± 37.2 153.2 ± 28.7</cell><cell>-6.0 ± 35.0</cell><cell cols="3">162.0 ± 37.8 157.4 ± 25.6 -2.4 ± 34.8</cell></row><row><cell>IL-10, pg/mL IL-12, pg/mL TNF-α, pg/mL</cell><cell>3.1 ± 1.0 1.7 ± 0.9 4.7 ± 1.2</cell><cell>3.7 ± 3.5 1.3 ± 0.9 a 4.4 ± 1.0 a</cell><cell>-0.3 ± 2.6 -0.4 ± 0.5 -0.4 ± 1.0</cell><cell>3.1 ± 0.8 1.6 ± 1.0 4.8 ± 1.4</cell><cell>3.1 ± 0.7 2.0 ± 1.0 5.0 ± 1.3</cell><cell>0.1 ± 0.6 0.3 ± 1.0 b 0.4 ± 1.4 b</cell><cell>3.2 ± 1.3 2.0 ± 1.0 4.5 ± 1.1</cell><cell>3.4 ± 1.3 2.3 ± 0.9 5.2 ± 1.4 a</cell><cell>0.2 ± 1.2 0.3 ± 0.9 b 0.7 ± 0.7 b</cell></row><row><cell cols="10">Abbreviations: CCL2, chemokine (C-C motif) ligand 2; High-Dose Exercise, 300 minutes per week; IL-10, interleukin 10; IL-12, interleukin 12; Low-Dose Exercise,</cell></row><row><cell cols="4">150 minutes per week; TNF-α, tumor necrosis factor α.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="3">Data are presented as the mean ± SD. a P &lt; .05 within group.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note xml:id="_nuhx8FW"><p><s xml:id="_eN3jWxN">b P &lt; .05</s><s xml:id="_zjAU6nB">from control.</s></p></note></figure>
		</body>
		<back>

			<div type="funding">
<div><head xml:id="_UzvMJUm">FUNDING SUPPORT</head><p xml:id="_dYvygDG"><s xml:id="_EmrmtDj">Supported by the <rs type="funder">National Center for Advancing Translational Sciences</rs> (grants <rs type="grantNumber">UL1 TR002014</rs> and <rs type="grantNumber">KL2 TR002015</rs>) and the <rs type="funder">National Cancer Institute at the National Institutes of Health</rs> (grants <rs type="grantNumber">R01CA131333</rs> and <rs type="grantNumber">R25CA203650</rs>).</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_aJwQkrF">
					<idno type="grant-number">UL1 TR002014</idno>
				</org>
				<org type="funding" xml:id="_CjfApkx">
					<idno type="grant-number">KL2 TR002015</idno>
				</org>
				<org type="funding" xml:id="_jbK9YVE">
					<idno type="grant-number">R01CA131333</idno>
				</org>
				<org type="funding" xml:id="_4qZjs5g">
					<idno type="grant-number">R25CA203650</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_xhfCtCm">CONFLICT OF INTEREST DISCLOSURES</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_BK34Q4q">AUTHOR CONTRIBUTIONS</head><p xml:id="_6aFUFWK"><s xml:id="_sCtKKDB">Jeremy S. Haley: Investigation, data curation, formal analysis, and writingoriginal draft.</s><s xml:id="_nu3Kqeb">Elizabeth A. Hibler: Formal analysis and writing-review and editing.</s><s xml:id="_5nQdRWH">Shouhao Zhou: Formal analysis and writing-review and editing.</s><s xml:id="_JpPnWy6">Kathryn H. Schmitz: Funding acquisition, supervision, writing-review and editing, resources, and conceptualization.</s><s xml:id="_cFxTFdT">Kathleen M. Sturgeon: Investigation, data curation, writing-review and editing, project administration, and supervision.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main" xml:id="_Mr3a38w">Breast cancer information and support</title>
		<author>
			<persName><surname>Breastcancer</surname></persName>
		</author>
		<ptr target="https://www.breastcancer.org/" />
		<imprint>
			<date type="published" when="2018-08-29">August 29, 2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Breastcancer.org. Breast cancer information and support. Accessed August 29, 2018. https ://www.breas tcanc er.org/</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_FPPKQva">Oestrogen exposure and breast cancer risk</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Travis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Key</surname></persName>
		</author>
		<idno type="DOI">10.1186/bcr628</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pgJNwVw">Breast Cancer Res</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="239" to="247" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Travis RC, Key TJ. Oestrogen exposure and breast cancer risk. Breast Cancer Res. 2003;5:239-247. doi:10.1186/bcr628</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_BkEYhVu">Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays</title>
		<author>
			<persName><forename type="first">S</forename><surname>Rinaldi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kaaks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zeleniuch-Jacquotte</surname></persName>
		</author>
		<idno type="DOI">10.1158/1055-9965.epi-06-0960</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qJmktmu">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="48" to="52" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rinaldi S, Kaaks R, Zeleniuch-Jacquotte A, et al. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays. Cancer Epidemiol Biomarkers Prev. 2005;14:48-52. doi:10.1158/1055-9965. epi-06-0960</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_97s78xK">Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies</title>
		<author>
			<persName><forename type="first">T</forename><surname>Jarde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Caldefie-Chezet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Goncalves-Mendes</surname></persName>
		</author>
		<idno type="DOI">10.1677/erc-09-0043</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xsey3XY">Endocr Relat Cancer</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="1197" to="1210" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jarde T, Caldefie-Chezet F, Goncalves-Mendes N, et al. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies. Endocr Relat Cancer. 2009;16:1197-1210. doi:10.1677/ERC-09-0043</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_3zkFPqV">Association analysis identifies 65 new breast cancer risk loci</title>
		<author>
			<persName><forename type="first">K</forename><surname>Michailidou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lindstrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dennis</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature24284</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WW8twU9">Nature</title>
		<imprint>
			<biblScope unit="volume">551</biblScope>
			<biblScope unit="page" from="92" to="94" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Michailidou K, Lindstrom S, Dennis J, et al. Association analysis identifies 65 new breast cancer risk loci. Nature. 2017;551:92-94. doi:10.1038/natur e24284</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_TaVsvU7">Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Milne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename><surname>Kuchenbaecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Michailidou</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.3785</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CATbsav">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="1767" to="1778" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Milne RL, Kuchenbaecker KB, Michailidou K, et al. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nat Genet. 2017;49:1767-1778. doi:10.1038/ng.3785</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_s7aa8gb">Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair</title>
		<author>
			<persName><forename type="first">H</forename><surname>Bartsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nair</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00423-006-0073-1</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_D6wyzVQ">Langenbecks Arch Surg</title>
		<imprint>
			<biblScope unit="volume">391</biblScope>
			<biblScope unit="page" from="499" to="510" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bartsch H, Nair J. Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbecks Arch Surg. 2006;391:499-510. doi:10.1007/s00423-006-0073-1</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_8gt5bX8">Physical activity and risk of breast cancer: a meta-analysis of prospective studies</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kang</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10549-012-2396-7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7EmMBbV">Breast Cancer Res Treat</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page" from="869" to="882" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wu Y, Zhang D, Kang S. Physical activity and risk of breast can- cer: a meta-analysis of prospective studies. Breast Cancer Res Treat. 2013;137:869-882. doi:10.1007/s10549-012-2396-7</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_XsCDCBb">A prospective study of age-specific physical activity and premenopausal Cancer January 15, 2020 breast cancer</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Maruti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Willett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Feskanich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rosner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Colditz</surname></persName>
		</author>
		<idno type="DOI">10.1093/jnci/djn135</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tg7xbpb">J Natl Cancer Inst</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="728" to="737" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Maruti SS, Willett WC, Feskanich D, Rosner B, Colditz GA. A pro- spective study of age-specific physical activity and premenopausal Cancer January 15, 2020 breast cancer. J Natl Cancer Inst. 2008;100:728-737. doi:10.1093/jnci/ djn135</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_fJSCV8q">A review of the application of inflammatory biomarkers in epidemiologic cancer research</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Brenner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Scherer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Muir</surname></persName>
		</author>
		<idno type="DOI">10.1158/1055-9965.epi-14-0064</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wdKw29C">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1729" to="1751" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brenner DR, Scherer D, Muir K, et al. A review of the application of inflammatory biomarkers in epidemiologic cancer research. Cancer Epidemiol Biomarkers Prev. 2014;23:1729-1751. doi:10.1158/1055- 9965.EPI-14-0064</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_ksRmXEQ">Inflammatory markers in coronary heart disease</title>
		<author>
			<persName><forename type="first">M</forename><surname>Madjid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Willerson</surname></persName>
		</author>
		<idno type="DOI">10.1093/bmb/ldr043</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VSASGCQ">Br Med Bull</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="23" to="38" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Madjid M, Willerson JT. Inflammatory markers in coronary heart dis- ease. Br Med Bull. 2011;100:23-38. doi:10.1093/bmb/ldr043</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_AdQ4SfT">Tumour necrosis factor and cancer</title>
		<author>
			<persName><forename type="first">F</forename><surname>Balkwill</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrc2628</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZysVeAX">Nat Rev Cancer</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="361" to="371" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009;9:361-371. doi:10.1038/nrc2628</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_zHnQ7eh">CCL2 (monocyte chemoattractant protein-1) and cancer</title>
		<author>
			<persName><forename type="first">I</forename><surname>Conti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Rollins</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.semcancer.2003.10.009</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VxnFBWD">Semin Cancer Biol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="149" to="154" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Conti I, Rollins BJ. CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol. 2004;14:149-154. doi:10.1016/j.semca ncer.2003.10.009</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_uYMv6jp">Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression</title>
		<author>
			<persName><forename type="first">H</forename><surname>Fujimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sangai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ishii</surname></persName>
		</author>
		<idno type="DOI">10.1002/ijc.24378</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_T5HBUGc">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="1276" to="1284" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fujimoto H, Sangai T, Ishii G, et al. Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and con- tributes to tumor progression. Int J Cancer. 2009;125:1276-1284. doi:10.1002/ijc.24378</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_XfV3VnY">Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/ IL-12 synthesis in accessory cells</title>
		<author>
			<persName><forename type="first">A</forename><surname>D'andrea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Aste-Amezaga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Valiante</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kubin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Trinchieri</surname></persName>
		</author>
		<idno type="DOI">10.1084/jem.178.3.1041</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5mUd8JV">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">178</biblScope>
			<biblScope unit="page" from="1041" to="1048" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
	<note type="raw_reference">D&apos;Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gam- ma-production by suppressing natural killer cell stimulatory factor/ IL-12 synthesis in accessory cells. J Exp Med. 1993;178:1041-1048.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_NpxkBU3">Macrophage deactivation by interleukin 10</title>
		<author>
			<persName><forename type="first">C</forename><surname>Bogdan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Vodovotz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Nathan</surname></persName>
		</author>
		<idno type="DOI">10.1084/jem.174.6.1549</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zTfaqzV">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">174</biblScope>
			<biblScope unit="page" from="1549" to="1555" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by inter- leukin 10. J Exp Med. 1991;174:1549-1555.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_euUkTUm">Regulation of reactive-oxygenspecies generation in fibroblasts by Rac1</title>
		<author>
			<persName><forename type="first">M</forename><surname>Sundaresan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">X</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">J</forename><surname>Ferrans</surname></persName>
		</author>
		<idno type="DOI">10.1042/bj3180379</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cd95Wkc">Biochem J</title>
		<imprint>
			<biblScope unit="volume">318</biblScope>
			<biblScope unit="issue">pt 2</biblScope>
			<biblScope unit="page" from="379" to="382" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sundaresan M, Yu ZX, Ferrans VJ, et al. Regulation of reactive-oxygen- species generation in fibroblasts by Rac1. Biochem J. 1996;318(pt 2): 379-382.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_cZ2VdWn">PALB2 links BRCA1 and BRCA2 in the DNA-damage response</title>
		<author>
			<persName><forename type="first">F</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cub.2009.02.018</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Hh6N33c">Curr Biol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="524" to="529" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zhang F, Ma J, Wu J, et al. PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Curr Biol. 2009;19:524-529. doi:10.1016/ j.cub.2009.02.018</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_zQV3gVU">Impact of long-term high-intensity interval and moderate-intensity continuous training on subclinical inflammation in overweight/obese adults</title>
		<author>
			<persName><forename type="first">J</forename><surname>Gerosa-Neto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Antunes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">Z</forename><surname>Campos</surname></persName>
		</author>
		<idno type="DOI">10.12965/jer.1632770.385</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pHw6KQf">J Exerc Rehabil</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="575" to="580" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gerosa-Neto J, Antunes BM, Campos EZ, et al. Impact of long-term high-intensity interval and moderate-intensity continuous training on subclinical inflammation in overweight/obese adults. J Exerc Rehabil. 2016;12:575-580. doi:10.12965/ jer.16327 70.385</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_jrWRsyc">The associations between leisure-time physical activity and inflammatory and coagulation markers related to cardiovascular disease: the ATTICA Study</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Panagiotakos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pitsavos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chrysohoou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kavouras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C; Attica</forename><surname>Stefanadis</surname></persName>
		</author>
		<author>
			<persName><surname>Study</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ypmed.2004.07.010</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uFvvuCd">Prev Med</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="432" to="437" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Panagiotakos DB, Pitsavos C, Chrysohoou C, Kavouras S, Stefanadis C; ATTICA Study. The associations between leisure-time physical activity and inflammatory and coagulation markers related to cardio- vascular disease: the ATTICA Study. Prev Med. 2005;40:432-437. doi:10.1016/j.ypmed.2004.07.010</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_DydhqVW">Response of oxidative stress and inflammatory biomarkers to a 12-week aerobic exercise training in women with metabolic syndrome</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Farinha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Steckling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Stefanello</surname></persName>
		</author>
		<idno type="DOI">10.1186/s40798-015-0011-2</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DbGXasp">Sport Med Open</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">19</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Farinha JB, Steckling FM, Stefanello ST, et al. Response of oxidative stress and inflammatory biomarkers to a 12-week aerobic exercise train- ing in women with metabolic syndrome. Sport Med Open. 2015;1:19. doi:10.1186/s40798-015-0011-2</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_d7x84B2">Moderate-intensity regular exercise decreases serum tumor necrosis factor-alpha and HbA1c levels in healthy women</title>
		<author>
			<persName><forename type="first">S</forename><surname>Tsukui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kanda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nishino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kondo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Kobayashi</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.ijo.0801373</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_T3hnwy2">Int J Obes Relat Metab Disord</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1207" to="1211" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tsukui S, Kanda T, Nara M, Nishino M, Kondo T, Kobayashi I. Moderate-intensity regular exercise decreases serum tumor necrosis fac- tor-alpha and HbA1c levels in healthy women. Int J Obes Relat Metab Disord. 2000;24:1207-1211.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_jkugRz7">Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers</title>
		<author>
			<persName><forename type="first">J</forename><surname>Lammert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lubinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gronwald</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10549-018-4694-1</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XtdN67k">Breast Cancer Res Treat</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="page" from="561" to="571" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lammert J, Lubinski J, Gronwald J, et al. Physical activity during ado- lescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2018;169:561- 571. doi:10.1007/s10549-018-4694-1</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_7c5Sg76">Women In Steady Exercise Research (WISER) Sister: study design and methods</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Schmitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">I</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kontos</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cct.2014.12.016</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_XpEAdPW">Contemp Clin Trials</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="17" to="30" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schmitz KH, Williams NI, Kontos D, et al. Women In Steady Exercise Research (WISER) Sister: study design and methods. Contemp Clin Trials. 2015;41:17-30. doi:10.1016/j.cct.2014.12.016</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_pSpwFUS">Dose-response effects of aerobic exercise on estrogen among women at high risk for breast cancer: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Schmitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">I</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kontos</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10549-015-3604-z</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BXRsAqz">Breast Cancer Res Treat</title>
		<imprint>
			<biblScope unit="volume">154</biblScope>
			<biblScope unit="page" from="309" to="318" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schmitz KH, Williams NI, Kontos D, et al. Dose-response ef- fects of aerobic exercise on estrogen among women at high risk for breast cancer: a randomized controlled trial. Breast Cancer Res Treat. 2015;154:309-318. doi:10.1007/s10549-015-3604-z</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_9nnnBkv">Exercise-induced doseresponse alterations in adiponectin and leptin levels are dependent on body fat changes in women at risk for breast cancer</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sturgeon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Digiovanni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Good</surname></persName>
		</author>
		<idno type="DOI">10.1158/1055-9965.epi-15-1087</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UyDPP8c">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1195" to="1200" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sturgeon K, Digiovanni L, Good J, et al. Exercise-induced dose- response alterations in adiponectin and leptin levels are dependent on body fat changes in women at risk for breast cancer. Cancer Epidemiol Biomarkers Prev. 2016;25:1195-1200. doi:10.1158/1055-9965. EPI-15-1087</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_eNST4a9">The doseresponse effects of aerobic exercise on body composition and breast tissue among women at high risk for breast cancer: a randomized trial</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kontos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Schnall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Schmitz</surname></persName>
		</author>
		<idno type="DOI">10.1158/1940-6207.capr-15-0408</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_N4cDdBp">Cancer Prev Res</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="581" to="588" />
			<date type="published" when="2016">2016</date>
			<pubPlace>Phila)</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Brown JC, Kontos D, Schnall MD, Wu S, Schmitz KH. The dose- response effects of aerobic exercise on body composition and breast tis- sue among women at high risk for breast cancer: a randomized trial. Cancer Prev Res (Phila). 2016;9:581-588. doi:10.1158/1940-6207. CAPR-15-0408</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_HR4Xks5">The effects of aerobic exercise on estrogen metabolism in healthy premenopausal women</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Phipps</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Schmitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Kurzer</surname></persName>
		</author>
		<idno type="DOI">10.1158/1055-9965.epi-12-1325</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8DdfhAd">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="756" to="764" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Smith AJ, Phipps WR, Thomas W, Schmitz KH, Kurzer MS. The ef- fects of aerobic exercise on estrogen metabolism in healthy premeno- pausal women. Cancer Epidemiol Biomarkers Prev. 2013;22:756-764. doi:10.1158/1055-9965.EPI-12-1325</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_5Gfe2Zs">Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Kriska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Knowler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Laporte</surname></persName>
		</author>
		<idno type="DOI">10.2337/diacare.13.4.401</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tH7F7Uj">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="401" to="411" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kriska AM, Knowler WC, LaPorte RE, et al. Development of ques- tionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care. 1990;13:401-411. doi:10.2337/diaca re.13.4.401</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_vVgqF6h">Simple Plex( TM ): a novel multi-analyte, automated microfluidic immunoassay platform for the detection of human and mouse cytokines and chemokines</title>
		<author>
			<persName><forename type="first">P</forename><surname>Aldo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Marusov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Svancara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>David</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mor</surname></persName>
		</author>
		<idno type="DOI">10.1111/aji.12512</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ADGu2ES">Am J Reprod Immunol</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="678" to="693" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Aldo P, Marusov G, Svancara D, David J, Mor G. Simple Plex( TM ): a novel multi-analyte, automated microfluidic immunoassay platform for the detection of human and mouse cytokines and chemokines. Am J Reprod Immunol. 2016;75:678-693. doi:10.1111/aji.12512</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_qGV7cfj">Controlling the false discovery rate: a practical and powerful approach to multiple testing</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Benjamini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hochberg</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.2517-6161.1995.tb02031.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_t4eZsbZ">J R Stat Soc B</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="289" to="300" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995;57:289-300. doi:10.1111/j.2517-6161.1995.tb020 31.x</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_TCdK8NZ">Relation between fat distributions and several plasma adipocytokines after exercise training in premenopausal and postmenopausal women</title>
		<author>
			<persName><forename type="first">H</forename><surname>Hayase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nomura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Abe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Izawa</surname></persName>
		</author>
		<idno type="DOI">10.2114/jpa.21.105</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CzEG4B3">J Physiol Anthropol Appl Human Sci</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="105" to="113" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hayase H, Nomura S, Abe T, Izawa T. Relation between fat distri- butions and several plasma adipocytokines after exercise training in premenopausal and postmenopausal women. J Physiol Anthropol Appl Human Sci. 2002;21:105-113.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_D6VqMqt">No reduction in C-reactive protein following a 12-month randomized controlled trial of exercise in men and women</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Ulrich</surname></persName>
		</author>
		<idno type="DOI">10.1158/1055-9965.epi-08-0088</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BkZksuz">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1714" to="1718" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Campbell KL, Campbell PT, Ulrich CM, et al. No reduction in C-reactive protein following a 12-month randomized controlled trial of exercise in men and women. Cancer Epidemiol Biomarkers Prev. 2008;17:1714-1718. doi:10.1158/1055-9965.EPI-08-0088</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_xnVDseN">Cytokine response to exercise and its modulation</title>
		<author>
			<persName><forename type="first">K</forename><surname>Suzuki</surname></persName>
		</author>
		<idno type="DOI">10.3390/antiox7010017</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uF5fEX9">Antioxidants</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">17</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Suzuki K. Cytokine response to exercise and its modulation. Antioxidants. 2018;7:17. doi:10.3390/antio x7010017</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_7Ba9EkU">CCL2-driven inflammation increases mammary gland stromal density and cancer susceptibility in a transgenic mouse model</title>
		<author>
			<persName><forename type="first">X</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Glynn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Hodson</surname></persName>
		</author>
		<idno type="DOI">10.1186/s13058-016-0796-z</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9qJJXsS">Breast Cancer Res</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page">4</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sun X, Glynn DJ, Hodson LJ, et al. CCL2-driven inflammation in- creases mammary gland stromal density and cancer susceptibility in a transgenic mouse model. Breast Cancer Res. 2017;19:4. doi:10.1186/ s13058-016-0796-z</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_wWcqFJS">Macrophage cytokines: involvement in immunity and infectious diseases</title>
		<author>
			<persName><forename type="first">Arango</forename><surname>Duque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Descoteaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<idno type="DOI">10.3389/fimmu.2014.00491</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5yMYSYP">Front Immunol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">491</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol. 2014;5:491. doi:10.3389/fimmu.2014.00491</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_GQtJaNY">The IL-12 family of cytokines in infection, inflammation and autoimmune disorders</title>
		<author>
			<persName><forename type="first">K</forename><surname>Gee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Guzzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Che</forename><surname>Mat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<idno type="DOI">10.2174/187152809787582507</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uAb6qNf">Inflamm Allergy Drug Targets</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="40" to="52" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gee K, Guzzo C, Che Mat N, Ma W, Kumar A. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets. 2009;8:40-52. doi:10.2174/18715 28097 87582507</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_eRKrZ6Z">Interleukin 12: still a promising candidate for tumor immunotherapy?</title>
		<author>
			<persName><forename type="first">W</forename><surname>Lasek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zagozdzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jakobisiak</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00262-014-1523-1</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ytCBZuF">Cancer Immunol Immunother</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="419" to="435" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lasek W, Zagozdzon R, Jakobisiak M. Interleukin 12: still a promising candidate for tumor immunotherapy? Cancer Immunol Immunother. 2014;63:419-435. doi:10.1007/s00262-014-1523-1</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
